MTP

Midatech Pharma PLC (MTP) | Rumor.io

Midatech Pharma

MTP

Attention (50-day avg)0%

Attention rank (50-day avg)#3,902

Bullish sentiment (50-day avg)0%

Price to earnings ratio-0.39

Market capitalization4.7M

Earnings per share-1.75

Dividend yield (TTM)—

Revenue (annual)578K

Net income (annual)-5.5M

Social

What share of all stock conversation is about MTP?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% +0	0% 0

Mar 11

Midatech Pharma plc ($MTP) may be a good investment opportunity.
$MTP is a promising company with a unique ticker symbol.
There is a market interest in the ticker symbol $MTP.

Generated by AI

Sentiment

Of the messages about MTP that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	0%	76.47% -23.53
Bearish	—	—	100%	23.53% +23.53

Bullish· Aug 26

$MTP is poised to revolutionize the DeFi space with its focus on privacy and security, making it a strong play in the market.
The asset's slow and steady growth is a sign of its sustainable value, making it a more realistic and attractive option for investors.
$MTP's innovative AI acceleration network and expanding user base are driving adoption and setting the stage for future success.

Bearish· Aug 14

$MTP has shown a history of volatility, rapidly increasing in price only to drop back down after a surge in volume.
The company's recent dilution news has led to a significant price increase, with some investors questioning the legitimacy of the pump.
$MTP's chart has shown a parabolic short setup, with some traders taking advantage of the opportunity to short the stock, but others are warning of a potential bounce.

Generated by AI

Topics

Of the messages about MTP that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Macro	—	100%	40%	45.16%
Technical Analysis	—	0%	35%	38.71%
Announcements	—	0%	25%	16.13%
Analysts	—	0%	0%	0%
Controversies	—	0%	0%	0%
Earnings	—	0%	0%	0%

Jun 1

Midatech Pharma plc ($MTP) has been granted FDA Fast Track designation for MTX110, a treatment for recurrent glioblastoma.
The Fast Track designation is expected to expedite the development and review of MTX110 for the treatment of recurrent glioblastoma.
Midatech Pharma's shares have risen significantly following the announcement of the FDA Fast Track designation, with some posts noting gains of up to 33.33%.

Generated by AI

Community

Of the messages about MTP, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	42.86%	9.38%	4.07%
Newcomers	0%	57.14%	90.63%	95.93%

Regulars· Feb 3

Midatech Pharma plc has received a non-compliance notice from Nasdaq due to its failure to meet the minimum bid price requirement.
The company's stock price has been affected by its struggles to meet the Nasdaq listing requirements, which may impact its investors.
Midatech's receipt of the NASDAQ notice may lead to a potential delisting, which could have significant consequences for the company and its shareholders.

Newcomers· Jun 10

Newcomers to the MTP stock are focused on the upcoming presentation of MTX110 study results at ISPNO 2022, which could impact the stock's performance.
The retirement of Midatech Pharma's Chairman and the proposed new Chairman are being discussed by newcomers to the MTP stock, which may have implications for the company's leadership.
Newcomers to the MTP stock are also interested in the biotech sector, with $CBIO and $MTP being mentioned in the context of trending biotech stocks.

Generated by AI

Also Discussed

Investors talking about MTP also mention

#	Name	Attention
1	Matthews China Active ETFMCH	0%0
2	OBLN - Obalon Therapeutics, Inc.	——
3	SGRP - SPAR Group, Inc.	——
4	Precipio Inc.PRPO	0%0
5	JNCE - Jounce Therapeutics, Inc.	——
6	Bio-Path Holdings Inc.BPTH	0%0
7	KOGEKOGE	0%new
8	ENTR - ERShares Entrepreneur ETF	——
9	Alterity Therapeutics Ltd ADRATHE	0%0
10	Kaixin HoldingsKXIN	0%0

Midatech Pharma PLC

Website

Location

United States

Social

What share of all stock conversation is about MTP?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% +0	0% 0

Mar 11

Midatech Pharma plc ($MTP) may be a good investment opportunity.
$MTP is a promising company with a unique ticker symbol.
There is a market interest in the ticker symbol $MTP.

Generated by AI

Sentiment

Of the messages about MTP that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	0%	76.47% -23.53
Bearish	—	—	100%	23.53% +23.53

Bullish· Aug 26

$MTP is poised to revolutionize the DeFi space with its focus on privacy and security, making it a strong play in the market.
The asset's slow and steady growth is a sign of its sustainable value, making it a more realistic and attractive option for investors.
$MTP's innovative AI acceleration network and expanding user base are driving adoption and setting the stage for future success.

Bearish· Aug 14

$MTP has shown a history of volatility, rapidly increasing in price only to drop back down after a surge in volume.
The company's recent dilution news has led to a significant price increase, with some investors questioning the legitimacy of the pump.
$MTP's chart has shown a parabolic short setup, with some traders taking advantage of the opportunity to short the stock, but others are warning of a potential bounce.

Generated by AI

Topics

Of the messages about MTP that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Macro	—	100%	40%	45.16%
Technical Analysis	—	0%	35%	38.71%
Announcements	—	0%	25%	16.13%
Analysts	—	0%	0%	0%
Controversies	—	0%	0%	0%
Earnings	—	0%	0%	0%

Jun 1

Midatech Pharma plc ($MTP) has been granted FDA Fast Track designation for MTX110, a treatment for recurrent glioblastoma.
The Fast Track designation is expected to expedite the development and review of MTX110 for the treatment of recurrent glioblastoma.
Midatech Pharma's shares have risen significantly following the announcement of the FDA Fast Track designation, with some posts noting gains of up to 33.33%.

Generated by AI

Community

Of the messages about MTP, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	42.86%	9.38%	4.07%
Newcomers	0%	57.14%	90.63%	95.93%

Regulars· Feb 3

Midatech Pharma plc has received a non-compliance notice from Nasdaq due to its failure to meet the minimum bid price requirement.
The company's stock price has been affected by its struggles to meet the Nasdaq listing requirements, which may impact its investors.
Midatech's receipt of the NASDAQ notice may lead to a potential delisting, which could have significant consequences for the company and its shareholders.

Newcomers· Jun 10

Newcomers to the MTP stock are focused on the upcoming presentation of MTX110 study results at ISPNO 2022, which could impact the stock's performance.
The retirement of Midatech Pharma's Chairman and the proposed new Chairman are being discussed by newcomers to the MTP stock, which may have implications for the company's leadership.
Newcomers to the MTP stock are also interested in the biotech sector, with $CBIO and $MTP being mentioned in the context of trending biotech stocks.

Generated by AI

Midatech Pharma

Social

Mar 11

Sentiment

Bullish· Aug 26

Bearish· Aug 14

Topics

Jun 1

Community

Regulars· Feb 3

Newcomers· Jun 10

Also Discussed

Midatech Pharma PLC

Company Information

Location

Also Discussed

Social

Mar 11

Sentiment

Bullish· Aug 26

Bearish· Aug 14

Topics

Jun 1

Community

Regulars· Feb 3

Newcomers· Jun 10